It is important to remember that units do not tell you the strength of the medication on their own
Semaglutide is FDA approved to help reduce the risk of serious cardiovascular events, including heart attacks, strokes, and cardiovascular death, in people with established heart disease who are overweight or obese
If you meet the BMI criteria and have been unsuccessful with other weight management methods, your provider may recommend semaglutide as part of a well-structured plan
Stopping the medication removes the pharmacological support that helped achieve the transformation, leaving individuals fighting against increased appetite, reduced metabolic rate, and hormonal changes that promote weight regain
Brand-name injectable costs Mounjaro and Zepbound carry list prices exceeding $1,000 per month